RecruitingNCT06625684

Key Longitudinal Associations With Risk and Glioblastoma Outcomes


Sponsor

Duke University

Enrollment

200 participants

Start Date

Dec 10, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to find out what factors affect the health and risks in adults with glioblastoma (GBM), a grade 4 brain cancer. The main questions it aims to answer are: * How do genetic and immune system factors impact survival and quality of life in GBM patients? * What occupational and medical history factors are linked to the risk of getting GBM? Participants will: * Fill out an online survey about their medical history and lifestyle. Participants will have the chance to give a blood sample (from the outer arm) for genetic and immune system testing. Blood samples will be given using a home collection kit provided by the study team.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study follows people diagnosed with glioblastoma — an aggressive type of brain tumor — over time to identify factors that affect survival and treatment outcomes. It is an observational study using online surveys, not an experimental treatment. **You may be eligible if...** - You are at least 18 years old - You have been diagnosed with glioblastoma (GBM) or a grade 4 brain tumor, confirmed by biopsy - You have a working email address and are willing to complete online surveys - You can read English or Spanish **You may NOT be eligible if...** - You cannot read English or Spanish - You are unable to access or complete an online survey Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Duke University

Durham, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06625684


Related Trials